We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Available until 12/31/2020

Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.

Already Have An Account? Log in Now

Journal Scan / Research · June 24, 2020

Efficacy of Almitrine in the Treatment of Hypoxemia in SARS-CoV-2 Acute Respiratory Distress Syndrome





This abstract is available on the publisher's site.

Access this abstract now

Additional Info

Disclosure statements are available on the authors' profiles:

Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome
Chest 2020 Jun 05;[EPub Ahead of Print], R Barthélémy, PL Blot, A Tiepolo, A Le Gall, C Mayeur, S Gaugain, L Morisson, E Gayat, A Mebazaa, BG Chousterman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading